Bisphosphonates reduced complex regional pain syndrome pain intensity in the short term but not other time scales.

When Amber Meade twisted her ankle and broke a bone in her foot, she expected recovery to be easy. She needed surgery to shave down the damaged bone and make sure the nerves and tendons in her foot ...

Ambros Therapeutics, Inc. today announced its launch as a clinical-stage biotechnology company advancing late-stage therapies for severe, underserved diseases beginning with neridronate for Complex ...

According to the Company, a phase 2 trial will begin enrollment by the end of 2025. The Food and Drug Administration (FDA) has granted Orphan Drug designation to BRC-002 for the treatment of complex ...